{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:38:10Z","timestamp":1790206690574,"version":"4.1.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,15]]},"DOI":"10.2146\/news110046","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T18:21:38Z","timestamp":1309458098000},"page":"1276-1276","source":"Crossref","is-referenced-by-count":4,"title":["Fidaxomicin approved for <i>C. difficile<\/i> infections"],"prefix":"10.1093","volume":"68","author":[{"given":"Kate","family":"Traynor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/68\/14\/1276\/28349817\/ajhp1276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T01:45:40Z","timestamp":1555033540000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/68\/14\/1276\/5129439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,15]]},"references-count":0,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2011,7,15]]}},"URL":"https:\/\/doi.org\/10.2146\/news110046","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,7,15]]},"published":{"date-parts":[[2011,7,15]]}}}